Professor of Infectious Diseases; Associate Chief Medical Officer in Infectious Diseases
University of Miami Miller School of Medicine, Miami Transplant Institute and Jackson Health System
Miami, FL, United States
Lilian M Abbo, M.D, MBA, FIDSA.
Dr. Lilian Abbo, is the Associate Chief Medical Officer for Infectious Diseases at Jackson Health System and a Professor of Clinical Infectious Diseases at the University of Miami Miller School of Medicine and the Miami Transplant Institute.She is a patient advocate, executive health system leader and frontline infectious diseases expert managing infection prevention and antimicrobial stewardship through a complex ecosystem in Miami, Florida. She oversees across Jackson Health System, 7 acute care hospitals (including pediatrics and behavioral health), 2 nursing homes, 5 urgent care centers and 3 of the Miami Dade County jails.
Dr Abbo graduated from the Universidad Central de Venezuela and completed her residency trainings at Jacobi Medical Center, NY and Mount Sinai Medical Center, Miami Beach, and a fellowship in Infectious Diseases at Jackson Memorial Hospital. She holds an Executive master’s in business administration (MBA) from the University of Miami Herbert Business School.
She co-authored over 130 peer-reviewed publications, several book chapters, and has been an invited speaker in hundreds national and international meetings. Frequently interviewed by local, National, and international media outlets for her expertise in Infectious Diseases. Her research is focused on the management of complex solid organ transplant patients with multidrug resistant infections, infection prevention and antimicrobial stewardship.
Dr Abbo is the past president of Women in Academic Medicine at the University of Miami Miller School of Medicine; fellow of the 25th Executive Leadership in Academic Medicine (ELAM) Program for Women at Drexel University College of Medicine; fellow of the Infectious Diseases Society of America (IDSA), has served in multiple committes (American Society of Transplantation, SHEA and IDSA). Currently she is the first hispanic woman to serve in the IDSA Board of Directors.
Disclosure(s): Ferring: Advisor/Consultant (); Pfizer: Advisor/Consultant (); Regeneron: Grant/Research Support (); Shionogi: Advisor/Consultant ()
114 - Meet Me in the Metaverse: AI in ID
Friday, October 13, 2023
10:30 AM – 11:45 AM US ET
175 - C. diff, C. auris, MDROs, Oh My
Friday, October 13, 2023
1:45 PM – 3:00 PM US ET
Saturday, October 14, 2023
10:30 AM – 10:42 AM US ET